Article
Variability of the drug response to nonsteroidal anti-inflammatory drugs according to cyclooxygenase-2 genetic polymorphism.
Drug design, development and therapy - 1 Jan 2017
Lee Sook Joung, Park Min Kyu, Shin Dong-Seong, Chun Min Ho
Abstract excerpt
PURPOSE: Cyclooxygenase (COX) is the main pharmacodynamic target of nonsteroidal anti-inflammatory drugs (NSAIDs). We investigated the inhibitory effects on COX-2 after NSAIDs administration using a lipopolysaccharide (LPS)-derived COX-2 induction model in whole blood, according to the genotypes of COX-2 single-nucleotide polymorphisms (SNPs). PATIENTS AND METHODS: Seven genotypes of COX-2 SNPs were selected from...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
